In AD patients or mouse models carrying the Osaka mutation, pronounced cognitive impairments, cellular stress, synaptic spine loss, and, critically, pathological tau phosphorylation and conformational changes are observed [33, 65]. This evidence concerns the gene MAPT and Alzheimer disease.